ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 117 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $481,000 | +314.7% | 7,592 | +85.9% | 0.00% | +200.0% |
| Q3 2019 | $116,000 | -54.5% | 4,084 | -57.7% | 0.00% | -50.0% |
| Q2 2019 | $255,000 | +35.6% | 9,653 | -5.9% | 0.00% | 0.0% |
| Q1 2019 | $188,000 | +72.5% | 10,263 | +18.4% | 0.00% | +100.0% |
| Q4 2018 | $109,000 | +13.5% | 8,670 | +73.4% | 0.00% | 0.0% |
| Q3 2018 | $96,000 | -68.4% | 5,000 | -77.7% | 0.00% | -75.0% |
| Q2 2018 | $304,000 | +60.0% | 22,381 | -15.2% | 0.00% | +33.3% |
| Q1 2018 | $190,000 | +265.4% | 26,381 | +87.1% | 0.00% | +200.0% |
| Q4 2017 | $52,000 | -13.3% | 14,100 | +1.8% | 0.00% | 0.0% |
| Q3 2017 | $60,000 | +361.5% | 13,850 | +73.1% | 0.00% | – |
| Q2 2017 | $13,000 | +160.0% | 8,000 | +220.0% | 0.00% | – |
| Q1 2017 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2016 | $4,000 | -77.8% | 2,500 | -0.7% | 0.00% | – |
| Q3 2016 | $18,000 | +38.5% | 2,518 | 0.0% | 0.00% | – |
| Q2 2016 | $13,000 | – | 2,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |